Innovative Neurotechnologies, Inc

Description

• Innovative NeuroTechnologies, Inc. (INT) is a development-stage biotechnology company operating in virtual mode that is currently pursuing a pipeline of novel biologically-based and disease-modifying therapeutic solutions to prevent, delay, or mitigate the underlying dementia or cognitive decline associated with a spectrum of neurodegenerative disorders referred to as tauopathies, which includes: Alzheimers disease (AD), Frontotemporal dementia (FTD or Picks disease), Chronic traumatic encephalopathy (CTE) or dementia pugilistica, Progressive supranuclear palsy (PSP), Corticobasal degeneration (CBD), Familial form of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), and Parkinson's disease dementia (PDD). The pathology of these seemingly disparate conditions is similar in that they involve dysregulation of the Tau protein and development of neurofibrillary tangles (NFTs), synaptic dysfunction, and/or neuronal loss, which underlie the observed dementia or cognitive deficits. Unfortunately, there are no effective therapies presently available for this spectrum of disorders, and neurodegenerative tauopathies remain a very significant socioeconomic burden and tremendous unmet medical need worldwide.
• 

  Headquarters:430 Goddard , Irvine, California, United States

  More
• 

  Phone Number: +1 949-453-8240

• 

  Website: https://www.innovneurotech.com

• 

  Employees:2

• 

  Revenue:$1 - 10M

• 

  Legal Name:Innovative Neurotechnologies, Inc

• Innovative Neurotechnologies, Inc's Social Media

  
• Is this data correct?

• |  NAICS Code: 541715  |

  Show More